Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?

Bibi Kulsoom,1 Tahir Sultan Shamsi,1 Nasir Ali Afsar,2,3 Zahida Memon,4 Nikhat Ahmed,4 Syed Nazrul Hasnain5 1National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan; 2Jinnah Medical and Dental College, Karachi, Pakistan; 3College of Medicine, Alfaisal University, Riya...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Kulsoom B, Shamsi TS, Afsar NA, Memon Z, Ahmed N, Hasnain SN
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Dove Medical Press 2018-03-01
Serie:	Cancer Management and Research
Soggetti:	AML apoptosis chemoresistance Bcl-2 Bax-Bcl ratio Anti Bcl-2 Therapy
Accesso online:	https://www.dovepress.com/bax-bcl-2-and-baxbcl-2-as-prognostic-markers-in-acute-myeloid-leukemia-peer-reviewed-article-CMAR
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!